Silo Pharma Inc (SILO) Stock Price, Quote & News

Company Profile

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders....

Industry: Biotechnology

Sector: Healthcare

Phone: 718 400 9031

Website: silopharma.com

Address:

677 North Washington Boulevard, Sarasota, United States

MarketMasterMind Apr. 27 at 6:35 PM

$CMND | $SPRC | $SILO 🤑Ⓜ️

0 · Reply

MarketMasterMind Apr. 27 at 2:19 PM

$SILO loaded as much in this $.42-$.43 range as I can. Bounce coming soon 🤑Ⓜ️

0 · Reply

Eddytrader Apr. 27 at 12:08 PM

$SILO 🚀🚀🚀🚀

1 · Reply

MarketMasterMind Apr. 27 at 10:10 AM

$DKI | $GMEX | $SILO loading more 🤑Ⓜ️

0 · Reply

BadyBady Apr. 27 at 8:00 AM

$SILO

0 · Reply

_GoddessJasmine Apr. 24 at 9:33 PM

MITQ looking ready, keep eyes on this one. Latest news + contracts rolling in Low float (~sub 10M) NO dilution Record earnings trend 📈. MITQ super undervalued-The entire company trades at 5.5M. It’s sitting on $3.9M in cash. That means you’re effectively buying the entire operating business $18M+ in annual revenue, proprietary products. $GXAI $SILO $PN $FRMM ..ww/

0 · Reply

OfficialStocktwitsUser Apr. 24 at 9:26 PM

$SILO RSI: 58.59, MACD: 0.0486 Vol: 0.10, MA20: 0.45, MA50: 0.38 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

MarketMasterMind Apr. 24 at 7:56 PM

$CREG | $GMEX | $SILO 🤑Ⓜ️

0 · Reply

Jbjb90 Apr. 24 at 6:59 PM

$SILO it wants to run, keeps creeping to .4995 then dipping then right back, needs to close above .50 then next week back to .60

0 · Reply

Eddytrader Apr. 24 at 6:58 PM

$SILO 🚀🚀🚀🚀

0 · Reply

Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents

Apr 7, 2026, 9:40 AM EDT - 20 days ago

Silo Pharma Rallies After Securing Key Patent Allowance

Apr 7, 2026, 5:02 AM EDT - 20 days ago

Stock Market Today: Dow, S&P 500 Futures Rise Ahead Of Trump's 'Power Plant Day' Deadline—UnitedHealth, Silo Pharma, Phillips 66 In Focus

IVV PSX SPXL SPY SSO UPRO VOO

Apr 6, 2026, 4:15 PM EDT - 21 days ago

Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy

Feb 23, 2026, 4:15 PM EST - 2 months ago

Silo Pharma Announces Share Buyback Program

Feb 18, 2026, 8:28 AM EST - 2 months ago

Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio

Dec 30, 2025, 8:05 AM EST - 4 months ago

Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15

Nov 17, 2025, 8:05 AM EST - 5 months ago

Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD

Oct 29, 2025, 8:25 AM EDT - 6 months ago

Silo Pharma Selects Alphaledger's T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain

Oct 23, 2025, 8:45 AM EDT - 6 months ago

Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program

Oct 8, 2025, 8:45 AM EDT - 7 months ago

Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company's Commitment to Multi-Chain Growth

Oct 6, 2025, 8:10 AM EDT - 7 months ago

Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci)

Oct 1, 2025, 4:20 PM EDT - 7 months ago

Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Sep 30, 2025, 8:02 AM EDT - 7 months ago

Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Sep 16, 2025, 8:11 AM EDT - 7 months ago

Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy

Sep 9, 2025, 9:10 AM EDT - 8 months ago

Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug

Sep 3, 2025, 8:25 AM EDT - 8 months ago

Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio

Aug 21, 2025, 2:00 PM EDT - 8 months ago

Silo Pharma's Alzheimer's Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal

Aug 19, 2025, 8:05 AM EDT - 8 months ago

Silo Pharma's PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway

Aug 5, 2025, 8:32 AM EDT - 9 months ago

Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform

Jul 16, 2025, 8:45 AM EDT - 10 months ago

Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15

Jul 7, 2025, 8:15 AM EDT - 10 months ago

Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025

Jun 25, 2025, 8:38 AM EDT - 10 months ago

Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

Jun 25, 2025, 8:27 AM EDT - 10 months ago

Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.

HOTH

Jun 11, 2025, 9:00 AM EDT - 11 months ago

Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

Jun 5, 2025, 9:15 AM EDT - 11 months ago

Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

May 21, 2025, 8:55 AM EDT - 1 year ago

Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

May 16, 2025, 4:15 PM EDT - 1 year ago

Silo Pharma Announces Closing of $2 Million Public Offering

May 15, 2025, 9:15 AM EDT - 1 year ago

Silo Pharma Announces Pricing of $2 Million Public Offering

May 14, 2025, 4:07 PM EDT - 1 year ago

Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15

May 14, 2025, 8:40 AM EDT - 1 year ago

Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories

Apr 30, 2025, 8:11 AM EDT - 1 year ago

Silo Pharma's SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

Apr 28, 2025, 7:50 AM EDT - 1 year ago

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer's Drug

Mar 26, 2025, 8:40 AM EDT - 1 year ago

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment

Feb 26, 2025, 1:30 PM EST - 1 year ago

Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment

Feb 18, 2025, 8:50 AM EST - 1 year ago

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment

Feb 11, 2025, 7:45 AM EST - 1 year ago

Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia

Jan 22, 2025, 8:29 AM EST - 1 year ago

Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment

Jan 2, 2025, 8:45 AM EST - 1 year ago

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain

Dec 18, 2024, 7:35 AM EST - 1 year ago

Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia

Nov 29, 2024, 8:05 AM EST - 1 year ago

Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management

Nov 18, 2024, 8:40 AM EST - 1 year ago

Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders

Oct 31, 2024, 8:35 AM EDT - 1 year ago

Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant

Sep 10, 2024, 6:35 AM EDT - 1 year ago

Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD

Aug 14, 2024, 2:30 PM EDT - 1 year ago

Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic

Aug 7, 2024, 8:13 AM EDT - 1 year ago

Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide

Jul 26, 2024, 8:20 AM EDT - 1 year ago

Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference

Jul 22, 2024, 4:45 PM EDT - 1 year ago

Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jul 19, 2024, 8:01 AM EDT - 1 year ago

Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jul 18, 2024, 12:44 PM EDT - 1 year ago

Silo Pharma Finds Partner For Device Development for Intranasal PTSD Drug

MarketMasterMind Apr. 27 at 6:35 PM

$CMND | $SPRC | $SILO 🤑Ⓜ️

0 · Reply

MarketMasterMind Apr. 27 at 2:19 PM

$SILO loaded as much in this $.42-$.43 range as I can. Bounce coming soon 🤑Ⓜ️

0 · Reply

Eddytrader Apr. 27 at 12:08 PM

$SILO 🚀🚀🚀🚀

1 · Reply

MarketMasterMind Apr. 27 at 10:10 AM

$DKI | $GMEX | $SILO loading more 🤑Ⓜ️

0 · Reply

BadyBady Apr. 27 at 8:00 AM

$SILO

0 · Reply

_GoddessJasmine Apr. 24 at 9:33 PM

0 · Reply

OfficialStocktwitsUser Apr. 24 at 9:26 PM

0 · Reply

MarketMasterMind Apr. 24 at 7:56 PM

$CREG | $GMEX | $SILO 🤑Ⓜ️

0 · Reply

Jbjb90 Apr. 24 at 6:59 PM

$SILO it wants to run, keeps creeping to .4995 then dipping then right back, needs to close above .50 then next week back to .60

0 · Reply

Eddytrader Apr. 24 at 6:58 PM

$SILO 🚀🚀🚀🚀

0 · Reply

MarketMasterMind Apr. 24 at 6:34 PM

$SILO | $CREG top two holds going into next week 🤑Ⓜ️

0 · Reply

Gymlover Apr. 24 at 6:00 PM

$SILO time to take off. Get ready .buckle up. 🚀🚀🚀🚀

0 · Reply

Gymlover Apr. 24 at 5:57 PM

$SILO squeeze 💪✈️✈️

0 · Reply

MarketMasterMind Apr. 24 at 3:24 PM

$SILO heavily invested here 🤑Ⓜ️

0 · Reply

Hfaistos Apr. 24 at 2:42 PM

$SILO $0.53 today

0 · Reply

jdkd4 Apr. 24 at 2:33 PM

$SILO @jacksparo yesterday was rough, I got this alert from Jack. Not a huge profit, but then again not bad for just placing an order, then setting a limit sell. I made my money for the day. Thank you, Jack for this great alert! Always take profit along the way, sure I could hold for more but I’m not gonna turn down 6K.!!!

2 · Reply

MarketMasterMind Apr. 24 at 2:32 PM

$SILO 🤑Ⓜ️

0 · Reply

Jbjb90 Apr. 24 at 2:24 PM

$SILO they plan to submit their IND for SpC-15 for PTSD, the FDA said they plan to start fast tracking these types of drugs. If that were to happen this will be a runaway train, there are many catalysts in play here as it sits at its bottom.

1 · Reply

MarketMasterMind Apr. 24 at 2:22 PM

$WHLR | $SILO | $ENVB 🤑Ⓜ️

0 · Reply

MarketMasterMind Apr. 24 at 2:17 PM

$SILO will be chasing at $1+ after lunch ⌛️ Ⓜ️

0 · Reply

MarketMasterMind Apr. 24 at 2:15 PM

$SCNI 🔥 $SILO 🙌🏻

1 · Reply

Gymlover Apr. 24 at 2:11 PM

$SILO 🚀🚀🚀🧨🚀🧨🧨🧨

0 · Reply

Market Cap	8.13M
Revenue (ttm)	70,000.00
Net Income (ttm)	-4.23M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-6,042.86%
Debt to Equity Ratio	0.00

Volume	880,997
Avg Vol	6,019,980
Day's Range	N/A - N/A
Shares Out	16.27M
Stochastic %K	38%
Beta	0.35
Analysts	Strong Sell
Price Target	$10.00